Second edition · September 2026 · regulatory cut-off 5 September 2026
For human medicines Annex 1 says “should”. For veterinary medicines, from 16 July 2026, the Regulation says “shall”.
220 pages and 17 editable tools to build the Contamination Control Strategy, demonstrate that it works and defend it in inspection. Every statement carries the clause it stands on, and a label declaring how much force that clause has: legal obligation, authority expectation, voluntary technical standard, or a decision the site has to justify.
220 pages (ENG) · 218 (ITA) · A4 PDF23 chapters in 6 parts + 5 appendices17 editable tools per languageItaliano and English109 verified sources16 verified inspection findings
Two editions, not two languages in one file. The guide and the toolkit exist in two editions only, Italian and English, with an identical structure: choose the ITA - Italiano or the ENG - English variant. The purchase gives access to the edition you choose.
The guide
23 chapters in six parts, from the clause to the decision and from the decision to the evidence that holds it up in inspection. 235 labels mark every statement: obligation, authority expectation, voluntary technical standard, association good practice, a decision to be justified, or a declared interpretation by the author.
The toolkit
17 editable tools per language — 10 Excel workbooks with formulas, drop-downs and consistency checks, and 7 Word documents with model text, revision history and approval tables. 34 files in all. No threshold, frequency or scale is pre-loaded: they are placeholders to be set with your own site’s rationale.
Lifetime updates
The picture is moving: the veterinary Regulation applies from 16 July 2026, PIC/S PI 006-4 comes into force on 1 October 2026, and ISO 14698-1 and -2 were withdrawn on 16 March 2026 with no ISO replacement. When the texts change you receive the revised guide and toolkit at no extra cost.
€149 — and it absorbs a product that used to cost €269
This edition absorbs the whole of the “Annex 1 Sterility Assurance Toolkit”, which GuideGxP sold separately at €269.00 and which is now retired as a standalone product. Clause-by-clause gap assessment, smoke study, aseptic interventions, material transfer routes, monitoring and the link between the CCS and the APS are all here, inside the 17 tools, together with the guide that explains why each file is built the way it is.
The first edition cost €129.00 for 61 pages and no editable files. This one costs €149.00 for 220 pages and 34 files. Anyone who bought the first edition receives this edition and the toolkit at no additional cost.
The 17 tools in the toolkit
Ten Excel and seven Word, in Italian and in English: 34 files. Every file carries at its head a code, version, date, site and the prepared / checked / approved lines; every checklist or matrix row carries the precise regulatory reference; every field that depends on the site is a “to be defined” placeholder and every example figure is marked as fictitious. No tool reproduces or adapts tables, figures or templates from ISO, PDA, ISPE, USP or ASTM.
EXCEL
01 · Sixteen Element Coverage Matrix
Element by element: full, partial or absent coverage, document, evidence, gap, action and owner. A second sheet handles the fourteen items of the veterinary list, with the three points of divergence.
EXCEL
02 · Annex 1 to CCS Gap Assessment and Cited-References Register
The forty Annex 1 clauses that name the CCS, pre-loaded: what the CCS has to decide, where the site does it today, gap, action and evidence. One sheet checks clause numbers against the section maxima.
EXCEL
03 · System Interaction Register
The section almost no real CCS has: pair by pair, what happens to B if A changes, which control governs it, and which monitoring would detect it.
EXCEL
04 · Contamination Control Plan by Line and Process
Step by step: potential contaminant, critical control point, control measure under the four categories of §2.3, monitoring, and the limit with the source of the limit.
EXCEL
05 · Contamination Risk Assessment (CRA)
An explicit risk question and an acceptability criterion declared in advance on a separate, dated sheet. No scale, threshold or RPN is pre-loaded.
EXCEL
06 · Accepted Residual Risk Register
What remains after the controls, with a written rationale, conditions of validity, who accepts and under what authority, the date and the review date.
WORD
07 · Smoke Study and Airflow Visualisation Checklist
Checks that the study covers set-up, dynamic operations, each intervention and operator positions, and that it is repeated after modifications.
EXCEL
08 · Aseptic Intervention Register
A catalogue per line with category, expected frequency, authorisation and “simulated in the APS yes/no”. A second sheet records the interventions actually performed per batch, against those declared.
EXCEL
09 · Material Transfer Route Matrix
Route by route: starting and arrival grade, means, decontamination method, sporicide yes/no, hold time, monitoring and evidence. One sheet lists the route incompatibilities.
WORD
10 · APS Plan and Fill Volume Justification
Line × process × shift matrix, annual qualification (§9.38), six-monthly revalidation per operator for manual operations (§9.39), and the written justification of the number of units (§9.40).
WORD
11 · Cleaning and Disinfection Programme: Justification and Effectiveness
Agents, rotation and rationale, justified frequencies, sporicides, hold time and efficacy against the flora actually isolated at the site. No frequency, concentration or contact time is pre-loaded.
EXCEL
12 · Environmental, Process and Continuous-Parameter Monitoring Justification
Point by point: frequency with its rationale, limits with their source, justified alarm delays (§4.16), and the link between an excursion and the release decision.
EXCEL
13 · CCS Effectiveness KPI Dashboard
Every indicator with numerator, denominator and period, source, owner and reading criterion. No threshold is pre-loaded: a green dashboard does not demonstrate effectiveness.
WORD
14 · CCS Management Review Minutes
Material examined with its version, assessment of the collective effectiveness of the controls, tracked decisions, and formal closure of the actions from the previous review.
WORD
15 · CCS Change Impact Assessment, Before and After
Part A before implementation, Part B afterwards, with verification that the controls actually work. The two parts do not close at the same moment.
WORD
16 · CCS Model Document
A complete, fillable document: for each section, which clause asks for that content, whether it is to be included or referenced, and which tool feeds it. It contains the two sections almost no CCS has.
WORD
17 · Inspection Simulation Kit
A half-day mock audit, a question bank in the format question / evidence expected / red flag, an observation walk through the department, a scored self-assessment and the structure of the CCS file.
You can use it tomorrow morning
| The situation | What you use |
|---|
| I have to write the CCS of a sterile site from scratch |
Part III — Building the strategy (chs. 7-9) + Tools 01, 04, 05 and 16 |
| I have inherited a CCS written before 2023 |
Part I — What the sources actually say (chs. 1-4) + Tool 02: the forty clauses that name the CCS, and where the site meets them today |
| We also manufacture veterinary medicines and must comply from 16 July 2026 |
Chapter 3 and case 3 of chapter 22 + Tool 01, the fourteen-item sheet: the statutory list does not merge with the Annex 1 list |
| An observation says a risk is not assessed in the CCS |
Part VI — Proving it in inspection (chs. 21-23) + Tools 05 and 06, and case 4 of chapter 22 |
| I have to show the CCS is effective, not just that it exists |
Part V — Keeping the CCS alive (chs. 18-20) + Tools 13 and 14: indicators with a calculation definition, and a review with tracked decisions |
| An HVAC change reduces the air change rate |
Chapter 20 + Tool 15: Part A before, Part B afterwards, and case 5 of chapter 22 |
| I have to justify the number of units in the APS |
Chapter 14 + Tool 10: the justification §9.40 asks for, with no figures pre-loaded |
| I have an inspection in two weeks |
Chapter 23 + Tool 17: 42 questions with the evidence expected, 15 red flags and a 32-item self-assessment |
The legal asymmetry — and why this page does not say the CCS is mandatory
For human medicines no binding rule imposes a CCS. The obligation lives in EU GMP Annex 1 §2.3, a guideline adopted by the European Commission whose language is “should”, not “shall”. Annex 1 does not create the obligation: it specifies it. A site without a CCS is not in breach of Annex 1 — it turns up to the inspection without the instrument the inspector uses to verify that the statutory GMP obligation is met. Saying so makes the site’s own document more defensible, not less.
For veterinary medicines, from 16 July 2026, it is law. Implementing Regulation (EU) 2025/2091 is directly applicable in every Member State, with no transposition, and says “shall”: Annex I §II.3 requires a contamination control strategy to be developed by the manufacturer and implemented in the site, and Article 29(7) requires the strategy to address all the potential risks. The same document is an inspection expectation when you manufacture for humans and a legal obligation when you manufacture for animals. That is chapter 3 of this guide.
The two lists never add up and never merge. Annex 1 §2.5 lists sixteen elements, numbered i–xvi; the veterinary list in Annex I §II.5 has fourteen, unnumbered. The “fifteen” that circulates online and inside company CCS documents comes from merging items x and xi — that is, from reporting the veterinary list without knowing it. The guide sets them side by side item by item and always states which one is being invoked. And §2.3 establishes the CCS while §2.5 enumerates it: different clauses.
Eight labels, 235 of them in every edition. Every statement declares its own force:
[REQUIREMENT] [GUIDANCE] [STANDARD] [GOOD PRACTICE] [QRM] [GUIDEGXP] [DRAFT] [NOT YET APPLICABLE — from DD/MM/YYYY]
Annex 1 always carries [GUIDANCE], never [REQUIREMENT]. No binding verb is attached to PIC/S, ICH, WHO, ISO, CEN/EN, PDA, ISPE, USP or ASTM: they are recommendations or voluntary standards, and the guide says so.
Regulatory cut-off 5 September 2026, with a register of 109 verified sources carrying designation, edition, date and status, and a regulatory status matrix. The 16 findings in chapter 21 are read on published official documents — 6 FDA Warning Letters from 2025-2026 and 10 Statements of Non-Compliance from the EudraGMDP database, 2024-2026 — and are anonymised without exception: never a company name, a brand or a product. No invented figures and no false urgency: texts that are not yet applicable are marked with their date, and drafts stay drafts.
Inside the guide
Part I — What the sources actually say (chs. 1-4). How to use the guide; what Annex 1, the veterinary Regulation, PIC/S, WHO, the United States position and the other jurisdictions actually say, clause by clause; the legal asymmetry; the map of the forty Annex 1 clauses that name the CCS.
Part II — What the CCS is, and how far it reaches (chs. 5-6). The CCS as a strategy and not a document: interactions between systems and collective effectiveness. The scope: site, lines, products, and what happens beyond sterile manufacture.
Part III — Building the strategy (chs. 7-9). The nine-step method, from scope to gap analysis; the QRM that holds the CCS up and the accepted residual risk; the voluntary technical framework, with what is live and what has been withdrawn.
Part IV — The sixteen elements in practice (chs. 10-17). What the CCS has to decide, justify and document on design and premises, personnel and aseptic interventions, utilities, materials and vendors, validation and APS, cleaning and disinfection, monitoring, prevention and continuous improvement.
Part V — Keeping the CCS alive (chs. 18-20). Writing the CCS: structure, model text and what not to write. Governance, ownership, review and effectiveness. Change control: impact assessed before and after.
Part VI — Proving it in inspection (chs. 21-23). The 16 verified inspection findings and the dominant themes; 5 complete worked scenarios; inspection readiness with 42 questions, 15 red flags and a 32-item self-assessment.
Plus five appendices. The register of 109 verified sources; the regulatory status matrix; 46 decisions the book asks you to make, each mapped to chapter, document, tool, evidence and owner; 17 tool sheets; a glossary of 73 entries.
Where this guide stops
This guide — the strategy
What the CCS has to decide, justify and document on each theme; how it is built, kept alive and defended in inspection; who signs, where it is recorded, and which evidence holds.
Out of scope — the disciplines the strategy coordinates
Designing the environmental monitoring plan, HVAC sizing and cleanroom requalification, aseptic line design and VPHP cycles, qualification of PW/WFI systems, execution and investigation of media fills, the operative content of ISO 14644-5.
Chapter 6 says it openly: this guide governs the strategy and does not re-cover the disciplines the strategy coordinates. Environmental Monitoring, Cleanroom & HVAC, Aseptic Fill-Finish & Barrier Systems, ISO 14644-5, Water & WFI and Media Fill/APS each have dedicated treatment in their own volumes in the GuideGxP series. We would rather tell you here than let you find out halfway through the book.
Read 16 pages before you buy
The free extract is made of 16 real pages of the English edition (17 of the Italian one), not a sales summary: the six technical rules that govern the book and the eight labels; the full table of contents with real page numbers; the sixteen elements of §2.5 set item by item against the fourteen veterinary items; the section on the day the CCS became law for veterinary medicines; one of the sixteen findings in full; and the complete list of the seventeen tools.
Specifications
| Format |
PDF A4 — 220 pages (ENG edition) · 218 pages (ITA edition) |
| Edition |
Second edition · September 2026 · version 2.0. Supersedes version 1.0 of January 2026. |
| Structure |
23 chapters in six parts + five appendices |
| Toolkit |
17 editable tools per language: 10 Excel workbooks and 7 Word documents — 34 files in all |
| Languages |
The guide and the toolkit exist in two editions only, Italian and English, with an identical structure: choose the ITA - Italiano or the ENG - English variant. |
| Sources |
A register of 109 verified sources with designation, edition, date and status |
| Regulatory cut-off |
5 September 2026 |
| Inspection case material |
16 verified, anonymised findings: 6 FDA Warning Letters (2025-2026) and 10 EudraGMDP Statements of Non-Compliance (2024-2026) |
| Delivery |
Immediate download after purchase |
| Licence |
Individual use, internal to the purchasing company |
| Update |
Anyone who bought the first edition receives this edition and the toolkit at no additional cost |
Who it is for. QA Managers and Heads of Quality, Qualified Persons, Microbiology and QC, sterile Manufacturing, Engineering and HVAC, Validation and CQV, Regulatory Affairs, Sterility Assurance, consultants and auditors, veterinary and mixed sites, CDMOs. It is written for readers who already have the regulations: it does not explain what contamination is and does not summarise GMP. It explains which decision to take, on what criterion, who signs it, in which document it is recorded and how it is defended in inspection.
Do you have to write, rebuild or defend your site’s CCS?
Describe the site, the scope (human, veterinary or mixed) and where you are stuck. GuideGxP will assess the request and, where appropriate, may put you in touch with a specialist suited to your technical needs and your region.
Describe the situation →
No purchase obligation. Every request is assessed before any referral to a specialist.
GuideGxP guides do not replace official regulations (EMA, EU GMP, ICH, PIC/S, ISO, EN, FDA, pharmacopoeias): they are operational support tools, and the user remains responsible for the correct application of the rules in force in their own company context. ISO, CEN/EN, PDA, ISPE, USP and ASTM documents are voluntary and paid-for: their full text must be purchased from the publishing body and is not reproduced here. Warning Letters state the FDA’s position on alleged violations and are not judicial findings. Digital product: no physical shipment.
